0,934  0,005  Antiinflammatory
0,907  0,005  Apoptosis agonist
0,872  0,003  Nitric oxide antagonist
0,819  0,009  Caspase 9 stimulant
0,782  0,010  Antineoplastic (lung cancer)
0,772  0,009  TNF expression inhibitor
0,755  0,004  AR expression inhibitor
0,755  0,005  Cardiovascular analeptic
0,734  0,005  Hepatic disorders treatment
0,733  0,016  Antineoplastic (breast cancer)
0,718  0,005  Antineoplastic (melanoma)
0,710  0,005  Antineoplastic (pancreatic cancer)
0,709  0,003  Antineoplastic (endocrine cancer)
0,691  0,005  Antipyretic
0,704  0,020  Transcription factor NF kappa B inhibitor
0,648  0,004  Hepatoprotectant
0,646  0,010  5 Hydroxytryptamine release stimulant
0,642  0,012  Antineoplastic (ovarian cancer)
0,622  0,009  NOS3 expression inhibitor
0,617  0,022  Antileukemic
0,608  0,012  Immunosuppressant
0,598  0,004  ICAM1 expression inhibitor
0,600  0,011  Antipruritic, allergic
0,601  0,013  Chemopreventive
0,613  0,025  Cyclophilin D inhibitor
0,613  0,025  Antidiabetic
0,586  0,003  Interferon gamma antagonist
0,560  0,005  Prostatic (benign) hyperplasia treatment
0,575  0,021  Prostate cancer treatment
0,542  0,004  Antiacne
0,556  0,019  Bone diseases treatment
0,543  0,009  Vasodilator
0,532  0,006  Hair growth stimulant
0,544  0,019  Sensitization
0,522  0,005  Contraceptive
0,521  0,004  Prostate disorders treatment
0,522  0,010  Vascular (periferal) disease treatment
0,526  0,016  NOS2 expression inhibitor
0,524  0,020  Antineoplastic (cervical cancer)
0,521  0,018  Antioxidant
0,506  0,004  Abortion inducer
0,516  0,016  Antineoplastic (multiple myeloma)
0,499  0,004  Antiviral (Influenza A)
0,512  0,019  Apoptosis antagonist
0,511  0,017  Antineoplastic (glioma)
0,503  0,024  Cytotoxic
0,472  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,487  0,022  Antiosteoporotic
0,468  0,005  Sodium/bile acid cotransporter inhibitor
0,460  0,005  Antiviral (Influenza)
0,465  0,011  Antiulcerative
0,478  0,024  Caspase 3 stimulant
0,476  0,024  Antipsoriatic
0,464  0,013  Antineoplastic (liver cancer)
0,469  0,020  Antidiabetic (type 2)
0,477  0,029  Antihypercholesterolemic
0,449  0,006  Protein-tyrosine phosphatase inhibitor
0,443  0,004  Contraceptive female
0,478  0,039  Antineoplastic (colorectal cancer)
0,472  0,034  Vasodilator, peripheral
0,466  0,028  Antifungal
0,470  0,038  Antineoplastic (colon cancer)
0,437  0,005  Antiviral (Hepatitis B)
0,442  0,021  UGT2B4 substrate
0,413  0,004  Gastrin inhibitor
0,431  0,032  Analeptic
0,400  0,002  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,439  0,042  Cholesterol antagonist
0,403  0,008  Lipocortins synthesis antagonist
0,426  0,040  Respiratory analeptic
0,397  0,010  Antipruritic, non-allergic
0,403  0,018  Transcription factor STAT3 inhibitor
0,392  0,016  UGT1A4 substrate
0,422  0,057  CYP3A4 substrate
0,378  0,014  UGT2B7 substrate
0,416  0,058  CYP2C9 substrate
0,385  0,043  Antineoplastic (brain cancer)
0,372  0,033  Antineoplastic (glioblastoma multiforme)
0,341  0,015  Phospholipase C inhibitor
0,353  0,033  Transcription factor STAT inhibitor
0,349  0,029  Antineoplastic (lymphocytic leukemia)
0,346  0,027  UDP-glucuronosyltransferase substrate
0,394  0,080  Antibacterial
0,370  0,059  Immunostimulant
0,350  0,041  Antiprotozoal (Leishmania)
0,311  0,003  Aldosterone antagonist
0,347  0,040  Proliferative diseases treatment
0,309  0,004  Inducible nitric-oxide synthase inhibitor
0,339  0,035  Antiparasitic
0,322  0,018  Antialcoholic
0,337  0,036  Angiogenesis stimulant
0,346  0,045  Chemoprotective
0,324  0,027  Antihelmintic
0,339  0,042  Free radical scavenger
0,302  0,005  Farnesoid X receptor antagonist
0,325  0,028  Anesthetic general
0,324  0,030  Wound healing agent
0,308  0,015  Diabetic nephropathy treatment
0,319  0,028  Platelet adhesion inhibitor
0,293  0,004  Transcription factor NF kappa B stimulant
0,338  0,051  Interleukin 2 agonist
0,332  0,046  Antihypoxic
0,291  0,012  Cholesterol synthesis inhibitor
0,332  0,055  Teratogen
0,287  0,012  UGT2B9 substrate
0,339  0,069  Antithrombotic
0,313  0,048  Cardiodepressant
0,311  0,047  Antineoplastic (renal cancer)
0,271  0,008  Contraceptive male
0,295  0,033  UGT1A1 substrate
0,283  0,024  Antiviral (Hepatitis)
0,271  0,014  LDLR expression enhancer
0,271  0,018  Acute respiratory distress syndrome (ARDS) treatment
0,255  0,005  Arachidonic acid antagonist
0,285  0,035  Muscle relaxant
0,274  0,027  Neurotrophic factor enhancer
0,257  0,011  UGT2B10 substrate
0,254  0,009  Androgen antagonist
0,272  0,027  Diuretic
0,302  0,058  Embryotoxic
0,276  0,034  P-glycoprotein inhibitor
0,304  0,065  CYP2C19 substrate
0,306  0,069  Metabolic disease treatment
0,288  0,057  Hypoglycemic
0,228  0,004  5-Alpha-reductase inhibitor
0,304  0,087  Calcium channel activator
0,234  0,023  Insulin secretagoues
0,225  0,016  Antihemorrhagic
0,267  0,061  Antineoplastic (lymphoma)
0,214  0,008  ABCA1 expression enhancer
0,258  0,053  Antihypertriglyceridemic
0,233  0,031  Antipruritic
0,233  0,032  UGT2B15 substrate
0,278  0,078  Hypoxia-inducible factor 1 alpha inhibitor
0,234  0,034  Antineoplastic (squamous cell carcinoma)
0,250  0,055  Antineoplastic enhancer
0,211  0,015  Cyclooxygenase 3 inhibitor
0,199  0,011  Pregnane X receptor agonist
0,215  0,027  Antifungal enhancer
0,192  0,005  Anabolic
0,265  0,079  GST M1-1 substrate
0,208  0,022  Autism spectrum disorders treatment
0,258  0,073  Interleukin agonist
0,208  0,024  Gout treatment
0,186  0,002  Heme oxygenase stimulant
0,223  0,039  UGT1A3 substrate
0,188  0,005  UGT2B11 substrate
0,242  0,065  UGT1A6 substrate
0,185  0,009  Postmenopausal disorders treatment
0,246  0,071  Antineoplastic (sarcoma)
0,253  0,078  5 Hydroxytryptamine uptake stimulant
0,249  0,075  Tumour necrosis factor alpha release inhibitor
0,254  0,080  Amyotrophic lateral sclerosis treatment
0,198  0,025  Antitussive
0,211  0,041  Liver fibrosis treatment
0,174  0,005  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,222  0,053  Insulin sensitizer
0,254  0,085  Renal disease treatment
0,181  0,013  Actinic keratosis treatment
0,255  0,088  Lipoprotein disorders treatment
0,167  0,004  RNA-directed RNA polymerase stimulant
0,225  0,062  Carcinogenic
0,200  0,038  Antirickettsial
0,170  0,010  CDC25A inhibitor
0,166  0,006  Androgen agonist
0,227  0,068  Antiparkinsonian, rigidity relieving
0,200  0,042  Lipid peroxidase inhibitor
0,165  0,007  3C-Like protease (SARS coronavirus) inhibitor
0,180  0,022  Choleretic
0,168  0,014  Opioid kappa receptor antagonist
0,157  0,006  Glycine receptor antagonist
0,176  0,027  Microtubule formation inhibitor
0,154  0,005  Na+ K+ transporting ATPase inhibitor
0,197  0,048  Antiviral (Herpes)
0,177  0,028  Adenylate cyclase stimulant
0,191  0,043  Anesthetic
0,166  0,019  AMP-activated protein kinase stimulant
0,197  0,052  Antihelmintic (Nematodes)
0,150  0,006  Opioid kappa receptor agonist
0,165  0,022  TRPA1 agonist
0,157  0,015  CC chemokine 6 receptor antagonist
0,218  0,077  Antiviral (HIV)
0,189  0,048  Antineoplastic (carcinoma)
0,163  0,024  UGT2B1 substrate
0,168  0,030  Liver cirrhosis treatment
0,248  0,112  CTGF expression inhibitor
0,202  0,069  Non-steroidal antiinflammatory agent
0,163  0,033  Growth stimulant
0,150  0,022  Nitric-oxide synthase inhibitor
0,176  0,052  Protein kinase stimulant
0,224  0,101  UGT1A9 substrate
0,196  0,074  Sedative
0,181  0,060  Toxic, respiratory center
0,130  0,009  Anticholelithogenic
0,208  0,089  RNA-directed DNA polymerase inhibitor
0,149  0,036  Endometrios treatment
0,129  0,016  Aromatase inhibitor
0,171  0,063  Interleukin 6 antagonist
0,169  0,060  Melanin inhibitor
0,109  0,005  Postcoital contraceptive
0,216  0,113  Antineoplastic (bladder cancer)
0,113  0,015  Estrogen agonist
0,231  0,132  Ca(v)3.3 blocker
0,133  0,035  Estrogen antagonist
0,102  0,005  Lipocortins synthesis agonist
0,151  0,055  Psychosexual dysfunction treatment
0,117  0,023  Bile acid receptor antagonist
0,137  0,043  Alcohol dehydrogenase substrate
0,213  0,120  Cardioprotectant
0,164  0,072  Antiviral (Hepatitis C)
0,147  0,056  Skin whitener
0,124  0,037  Antineoplastic antibiotic
0,179  0,095  VEGF expression inhibitor
0,088  0,005  Estrone sulfatase inhibitor
0,088  0,005  5-Alpha-reductase 1 inhibitor
0,213  0,130  CYP2D6 substrate
0,087  0,005  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,086  0,004  Glucose-6-phosphate dehydrogenase inhibitor
0,187  0,104  Hypolipemic
0,096  0,014  Transcription factor AP-1 inhibitor
0,103  0,022  T cell inhibitor
0,083  0,005  Pregnane X receptor antagonist
0,114  0,037  mTOR complex 1 inhibitor
0,085  0,009  Anesthetic inhalation
0,120  0,046  Antiinfertility, female
0,133  0,059  DNA polymerase I inhibitor
0,122  0,049  Expectorant
0,088  0,016  SULT2A1 substrate
0,101  0,030  Keratolytic
0,109  0,038  SULT1E1 substrate
0,204  0,134  Antiepileptic
0,101  0,032  mTOR complex 2 inhibitor
0,085  0,018  Nitric oxide donor
0,079  0,012  Potassium channel Kv1.3 blocker
0,072  0,006  Parathyroid hormone antagonist
0,189  0,123  Antihypotensive
0,140  0,075  Skeletal muscle relaxant
0,110  0,046  Estrogen receptor beta antagonist
0,067  0,004  Progesterone agonist
0,086  0,023  CDC25B inhibitor
0,141  0,079  Antidiabetic (type 1)
0,194  0,132  DNA synthesis inhibitor
0,093  0,031  Narcotic antagonist
0,080  0,020  Hypercalcemia treatment
0,103  0,044  Paget's disease treatment
0,120  0,062  Menstruation disorders treatment
0,220  0,166  FMO1 substrate
0,064  0,010  Glucocorticoid antagonist
0,062  0,008  p53 inhibitor
0,096  0,041  GABA A receptor agonist
0,086  0,032  Glycine receptor agonist
0,114  0,062  GABA receptor agonist
0,070  0,018  Acetyl-CoA transferase 2 inhibitor
0,061  0,010  Farnesoid X receptor agonist
0,067  0,017  Estradiol 17 beta-dehydrogenase inhibitor
0,057  0,007  5-Alpha-reductase 2 inhibitor
0,097  0,048  Glutamate release inhibitor
0,095  0,047  Tocolytic
0,126  0,078  Cocaine dependence treatment
0,212  0,167  Antineoplastic (osteosarcoma)
0,200  0,155  CYP1A2 substrate
0,061  0,017  Cholesterol esterase inhibitor
0,067  0,023  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,051  0,008  Tubulin agonist
0,065  0,023  Diacylglycerol O-acyltransferase inhibitor
0,108  0,068  SULT1A1 substrate
0,043  0,004  Corticosteroid-like
0,104  0,065  HDL-cholesterol increasing
0,220  0,181  Histamine release inhibitor
0,075  0,036  Bcl2 antagonist
0,056  0,020  Microtubule stabilization
0,091  0,055  Ornithine decarboxylase inhibitor
0,076  0,040  Premenstrual syndrome treatment
0,069  0,033  Antimycoplasmal
0,106  0,071  Antiviral (SARS coronavirus)
0,106  0,071  Antiviral (Coronavirus)
0,051  0,018  Progesterone antagonist
0,078  0,046  Lipase inhibitor
0,214  0,182  Ulceration
0,079  0,050  Estrogen receptor alpha antagonist
0,041  0,012  Cholesterol ester transfer protein antagonist
0,054  0,025  Mineralocorticoid receptor antagonist
0,100  0,072  Antiprotozoal (Toxoplasma)
0,113  0,085  Acetylcholinesterase inhibitor
0,043  0,017  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,114  0,087  Antihyperlipoproteinemic
0,032  0,007  Vitamin D receptor antagonist
0,034  0,009  Retinoid X gamma receptor agonist
0,210  0,185  Inflammatory Bowel disease treatment
0,026  0,002  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,028  0,006  Glucocorticoid agonist
0,084  0,063  Opioid antagonist
0,031  0,010  Hedgehog signaling activator
0,048  0,029  Adenylate cyclase 1 inhibitor
0,023  0,005  Telomerase stimulant
0,030  0,012  Retinoid X gamma receptor antagonist
0,026  0,010  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,020  0,004  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,073  0,058  Topoisomerase II alpha inhibitor
0,088  0,076  Protease inhibitor
0,024  0,012  Retinoid X beta receptor agonist
0,051  0,040  Acetyl-CoA transferase inhibitor
0,168  0,156  Radioprotector
0,151  0,140  Pneumotoxic
0,033  0,024  Estrogen receptor alpha agonist
0,021  0,011  Progesterone receptor B antagonist
0,023  0,014  Retinoic acid gamma receptor agonist
0,043  0,035  Phosphorylase inhibitor
0,059  0,051  Hyperparathyroidism treatment
0,108  0,101  Antimutagenic
0,040  0,033  Cholesterol absorption inhibitor
0,037  0,030  Retinoic acid alpha receptor agonist
0,017  0,010  Vitamin D receptor agonist
0,009  0,003  Transcortin receptor antagonist
0,022  0,016  GRP78 expression inhibitor
0,050  0,044  GABA receptor antagonist
0,266  0,261  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,074  0,070  Antispirochetal
0,010  0,006  Progesterone receptor A antagonist
0,041  0,037  Heme oxygenase inhibitor
0,019  0,016  Retinoic acid alpha receptor antagonist
0,086  0,084  Sulfotransferase substrate
0,035  0,035  GABA uptake inhibitor

